QUICK POLL
If imatinib, nilotinib, and dasatinib are all approved for front-line therapy of newly diagnosed chronic phase (CP) chronic myelogenous leukemia (CML), what would you recommend as front-line therapy for a 42-year-old man who presents with high-risk CML by both the Sokal and Hasford (Euro) scoring systems and who has no matched sibling donor?
2nd European Perspectives in
Head & Neck Cancer
24 - 25 April 2009
Prague, Czech Republic
Prague Marriott Hotel
Who Should Attend
This educational activity is intended for medical and radiation oncologists, surgeons, otolaryngologists and other healthcare professionals in active clinical practice interested or involved in the management of patients with cancers of the head and neck. No specialized knowledge or skills other than a general familiarity with cancer and its treatment is required for successful participation in this activity.
Educational Objectives
After successfully completing this educational activity, participants should be able to:
- Comment on methods of detection and prevention of cancers of the head and neck
- Discuss current approaches in prognosis and therapy of early and intermediate stage cancers of the head and neck
- Identify surgical advances in the treatment of head and neck cancers
- Discuss various treatment options and challenges in palliative care for head and neck cancer patients
- Identify contemporary and promising strategies for improved management of advanced and recurrent cancers of the head and neck
- Recognize how current research may impact disease management in the future
K. Kian Ang, MD, PhD MD
Anderson Cancer Center
Houston, Texas,
United States
Jean Bourhis, MD
Institut Gustave Roussy
Villejuif, France
Chris Boshoff, MD, PhD
Wolfson Institute for Biomedical Research
London, United Kingdom
Andrew Bottomley, PhD
European Organisation for Research and
Treatment of Cancer, EORTC
Brussels,
Belgium
Volker Budach, MD, PhD
Charité University Clinic
Berlin Germany
Bernard Devauchelle, MD
University of Amiens
Amiens, France
Andreas Dietz, MD, PhD
University of Leipzig
Leipzig, Germany
Marc Dom, MD
University Hospital Antwerp
Edegem, Belgium
Sandrine Faivre, MD, PhD
Hôpital Beaujon
Paris, France
Maura L. Gillison, MD, PhD
The Johns Hopkins Hospital
Baltimore, Maryland,
United States
Jan Klozar, MD
Charles University
Prague, Czech Republic
Rainald Knecht, MD
J.W. Goethe University
Frankfurt, Germany
Frederic Kolb, MD
Institut Gustave Roussy
Villejuif, France
Gabriela Kornek, MD
University Medical School of Vienna
Vienna, Austria
Johannes A. Langendijk, MD, PhD
University Medical Center Groningen
Groningen,The Netherlands
Jean-Louis Lefebvre,
MD, PhD
Centre Oscar Lambret
Lille, France
Lisa Licitra, MD
Fondazione IRCCS, Istituto Nazionale dei Tumori
Milan, Italy
Marco Merlano, MD
S. Croce General Hospital
Cuneo, Italy
Marshall Posner, MD
Dana-Farber Cancer Institute
Boston, Massachusetts,
United States
Coen Rasch, MD, PhD
The Netherlands Cancer Institute
Amsterdam, The Netherlands
Dirk Schrijvers, MD, PhD
Middelheim Hospital
Antwerp, Belgium
Jan B. Vermorken, MD, PhD
University Hospital Antwerp
Edegem, Belgium
Friday, 24 April 2009
8:30
Welcome and Introduction
Jean-Louis Lefebvre, MD, PhD and Jan B. Vermorken, MD, PhD
Session I: Oropharynx
9:00
State of the Art Lecture I
Jean Bourhis, MD
9:30
Debate: Can bioradiation replace chemoradiation?
Pro: K. Kian Ang, MD, PhD
Con: Johannes A. Langendijk, MD, PhD
10:30
Coffee Break
11:00
Case Studies
Volker Budach, MD, PhD
12:00
Lunch
13:00
Break
Session II: Meet the professor Parallel Sessions
13:30
Topic 1: Quality of life
Andrew Bottomley, PhD
Topic 2: HPV
Amanda Psyrri, MD
Topic 3: Alternating RT and CT for whom?
Marco Merlano, MD
Session III: Oral Cavity
Moderator: Andreas Dietz, MD, PhD
14:30
State of the Art II
Jean Louis Lefebvre MD, PhD
15:00
Coffee Break
15:30
Surgery in the treatment for oral cavity cancer
Bernard Devauchelle, MD
16:30
Clinical Cases
Andreas Dietz, MD, PhD
17:30
Adjourn
Saturday, 25 April 2009
Session IV: Meet the professor parallel sessions
8:30
Topic 1: Oral cancer, reconstructive surgery
Frederic Kolb, MD
Topic 2: Peduncal vs Freeflap
Marc Dom, MD
Topic 3: Management of pain
Dirk Schrijvers, MD, PhD
Session V: Failing patient: Recurrent and/or Metastatic
Moderator: Gabriela Kornek, MD
9:30
State of the Art III
Jan B. Vermorken, MD PhD
10:00
Coffee Break
10:30
Debate: Maintenance therapy is useful
Pro: Sandrine Faivre, MD, PhD
Con: Lisa Licitra, MD
11:30
Clinical Cases
Gabriela Kornek, MD
12:30
Lunch
Session VI: Meet the Professor Parallel Sessions
13:30
Topic 1: Molecular Targeting
Chris Boshoff, MD, PhD
Topic 2: Regional Chemotherapy
Coen Rasch, MD, PhD
Session VII: Larynx/Hypopharynx
Moderator: Rainald Knecht, MD
14:30
State of the Art IV
Jean Louis Lefebvre, MD, PhD
15:00
Coffee Break
15:30
Debate: CRT is the treatment of choice for locally advanced disease
Pro: Jan Klozar, MD
Con: Marshall Posner, MD
16:30
Clinical Cases
Rainald Knecht, MD
17:30
Summary from chairs and Adjourn
Registration Fees
Discounted . . . . . . . . . . . . . . . . . . . . . . . . . .€ 249
If payment received by 2 March 2009
Regular . . . . . . . . . . . . . . . . . . . . . . . . . . . . .€ 349
If payment received by 14 April 2009
Full/Onsite . . . . . . . . . . . . . . . . . . . . . . . . . . € 449
If payment received after 14 April 2009
To Register:
You may register online by 14 April 2009 or by calling Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the Congress. To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.
Payment:
To pre-register, registration and payment must be received no later than 14 April 2009. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the program is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card, check, or wire transfer. Checks should be payable to Imedex. To pay via wire transfer, you must add €50 to each wire transaction to cover bank charges. Include the full name of the attendee and the name of the Congress: European Head & Neck Cancer Conference. An attendee is not registered until full payment is received. Wire to: Bank of America, NA London, 1 Alie Street E1ADE London UK, Swift Code: BOFAGB22, Sort Code: 165050 Beneficiary: Bank of America Domestic Deposit #5687, Account #: 600895687029, Reference: Imedex, Inc. Account # 10726-118, IBAN: GB89 BOFA 1650 5095 6870 29.
Registration Fee Inclusions:
Registration fees include admittance to all scientific sessions, Congress materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the program.
Cancellation:
For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than 14 April 2009. The amount of registration fees remitted, minus a €90 administrative charge, will be refunded after the Congress. Substitutions are accepted with written notification. No refunds will be made if notice is received after 14 April 2009. Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this Congress should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.
Prague Marriott Hotel
V Celnici 8
Prague, 111 21 Czech Republic
Tel: +420 222 888 888
Fax: +420 222 888 889
www.marriott.com/prgdt
A majestic jewel in one of Europe’s most enchanting cities, the Prague Marriott Hotel is steps from Old Town Square and major attractions. This upscale hotel evokes classic European charm and welcomes you with elegant accommodations. The 293 spacious guestrooms offer comfortable work areas, high speed internet access, complimentary fitness center access, upgraded amenities and brand new bedding.
For the convenience of attendees, a limited number of rooms have been reserved until 22 March 2009 at a discounted rate of 5,450 CZK for single occupancy, plus VAT, currently at 9%. This rate includes daily buffet breakfast. This rate is not guaranteed outside the Congress dates or after 22 March 2009. To reserve your room please contact the Prague Marriott Hotel reservations department at +420 222 888 822 or visit the hotel’s website at www.marriott.com/prgdt.
To receive the group rate, callers must identify themselves as being with the IMEDEX European Perspectives in Head & Neck Cancer group. Internet users must enter the meeting promotional code: IMEIMEA. Reservation requests received after 22 March 2009 may not be guaranteed the group rate.
Invitation
Dear Colleagues,
It is with great pleasure that we invite you to the 2nd European Perspectives in Head and Neck Cancer Congress to be held 24-25 April 2009 in Prague, Czech Republic. This spring’s Congress promises to be one of the most comprehensive events in the field of head and neck cancers.
With a wealth of data in this rapidly evolving field, Perspectives in Head and Neck Cancer will review the state-of-the-art in head and neck oncology, covering detection and prevention, disease management, surgical advances, supportive care, advances in radiation therapy, imaging and biology and future therapeutic strategies. Internationally recognized thought leaders in research, surgery, otolaryngology, and medical and radiation oncology will focus on the new advancements in the field and how this data fits into your current practice.
We sincerely hope you will join us and your colleagues this spring, as your perspectives and contributions will add immeasurable value to this congress! The added benefit of visiting Prague in the spring will enhance this rewarding experience.
Sincerely,
K. Kian Ang, MD, PhD - Chair
Jean-Louis Lefebvre, MD, PhD - Chair
Jan B. Vermorken, MD, PhD - Chair
Jan Klozar, MD - Local Chair
Organizer:
Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Chairs:
K. Kian Ang, MD, PhD
M.D. Anderson Cancer Center
Houston, Texas, United States
Jean-Louis Lefebvre, MD, PhD
Centre Oscar Lambret
Lille, France
Jan B. Vermorken, MD, PhD
University Hospital Antwerp
Edegem, Belgium
Local Chair:
Jan Klozar, MD
Charles University
Prague, Czech Republic
Congress Location:
Prague Marriott Hotel
V Celnici 8
Prague, 111 21 Czech Republic
Tel: +420 222 888 888
Fax: +420 222 888 889
www.marriott.com/prgdt
Discounted Airfares:
Contact Congress travel agent, Williamsburg Travel, for assistance with your travel needs. Williamsburg Travel can also accommodate pre- and post-Congress extensions. Tel.: +1 (888) 232-9394 or +1 (770) 261-8613 Email: judit@willtrav.com
Italian Participants:
Fargo International Meetings & Conventions SRL has been appointed as the official agency for government authorization for Italian participants. You may contact them directly at:
Fargo International Meetings & Conventions SRL
Via Piattro Maroncelli 44/66, 50137 Firenze, Italy
Tel.: +39 055 600 555
Fax: +39 055 609 078
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda's content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2009 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
The following companies have provided educational grants in support of this Congress:
FOUNDING SUPPORTER
BRONZE
Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.